MDLN
Medline Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$32.16
−0.65%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +10.1%
- EBITDA
- +32.4%
- EPS
- +77.4%
Three-year CAGR
- Revenue
- +9.9%
- EBITDA
- +6.8%
- EBIT
- +36.5%
- Net income
- +122.6%
- EPS
- +118.3%
- Free cash flow
- -3.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026